Unknown

Dataset Information

0

Selective inhibitors and tailored activity probes for lipoprotein-associated phospholipase A(2).

ABSTRACT: Lipoprotein-associated phospholipase A(2) (Lp-PLA(2) or PLA(2)G7) binds to low-density lipoprotein (LDL) particles, where it is thought to hydrolyze oxidatively truncated phospholipids. Lp-PLA(2) has also been implicated as a pro-tumorigenic enzyme in human prostate cancer. Several inhibitors of Lp-PLA(2) have been described, including darapladib, which is currently in phase 3 clinical development for the treatment of atherosclerosis. The selectivity that darapladib and other Lp-PLA(2) inhibitors display across the larger serine hydrolase family has not, however, been reported. Here, we describe the use of both general and tailored activity-based probes for profiling Lp-PLA(2) and inhibitors of this enzyme in native biological systems. We show that both darapladib and a novel class of structurally distinct carbamate inhibitors inactivate Lp-PLA(2) in mouse tissues and human cell lines with high selectivity. Our findings thus identify both inhibitors and chemoproteomic probes that are suitable for investigating Lp-PLA(2) function in biological systems.

SUBMITTER: Nagano JM 

PROVIDER: S-EPMC3549684 | biostudies-literature | 2013 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Lipoprotein-associated phospholipase A(2) (Lp-PLA(2) or PLA(2)G7) binds to low-density lipoprotein (LDL) particles, where it is thought to hydrolyze oxidatively truncated phospholipids. Lp-PLA(2) has also been implicated as a pro-tumorigenic enzyme in human prostate cancer. Several inhibitors of Lp-PLA(2) have been described, including darapladib, which is currently in phase 3 clinical development for the treatment of atherosclerosis. The selectivity that darapladib and other Lp-PLA(2) inhibitor  ...[more]

Similar Datasets

Unknown Lipoprotein-associated phospholipase A2 activity and risk of recurrent stroke.
| S-EPMC2846303 | biostudies-literature
Unknown Lipoprotein-Associated Phospholipase A2 Activity as Potential Biomarker of Vascular Dementia.
| S-EPMC10045550 | biostudies-literature
Unknown Lipoprotein-associated phospholipase A2: The story continues.
| S-EPMC6973114 | biostudies-literature
Unknown Lipoprotein-Associated Phospholipase A2 Activity and Mass as Independent Risk Factor of Stroke: A Meta-Analysis.
| S-EPMC6545803 | biostudies-literature
Unknown Relationship of lipoprotein-associated phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis.
| S-EPMC2724786 | biostudies-literature
Unknown Identification of selective inhibitors of uncharacterized enzymes by high-throughput screening with fluorescent activity-based probes.
| S-EPMC2709489 | biostudies-literature
Unknown Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories.
| S-EPMC6443177 | biostudies-literature
Unknown Racial variation in lipoprotein-associated phospholipase A? in older adults.
| S-EPMC3146402 | biostudies-literature
Unknown Effect of darapladib treatment on endarterectomy carotid plaque lipoprotein-associated phospholipase A2 activity: a randomized, controlled trial.
| S-EPMC3930668 | biostudies-literature
Unknown Admission lipoprotein-associated phospholipase A2 activity is not associated with long-term clinical outcomes after ST-segment elevation myocardial infarction.
| S-EPMC4006846 | biostudies-literature